ASHLEA FREEMAN: Open Payments
NPI 1124492434 · WOLFFORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 15 payments from 6 companies in 2025. Trend: 2023 $1,034 · 2024 $460 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $243 |
| Otsuka America Pharmaceutical, Inc. | 5 | $138 |
| Axsome Therapeutics, Inc. | 2 | $129 |
| ABBVIE INC. | 1 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: CAPLYTA, Auvelity, ABILIFY MAINTENA, VRAYLAR, COBENFY, REXULTI, INGREZZA.
Industry payments across TX — which companies pay providers there.
